Related Experiment Video
Updated: Nov 22, 2025

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
Mitotic checkpoint defects: en route to cancer and drug resistance
Sinjini Sarkar1,2, Pranab Kumar Sahoo1, Sutapa Mahata1
1Department of Pathology and Cancer Screening, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata, West Bengal, 700026, India.
Abstract:
Loss of mitosis regulation is a common feature of malignant cells that leads to aberrant cell division with inaccurate chromosome segregation. The mitotic checkpoint is responsible for faithful transmission of genetic material to the progeny. Defects in this checkpoint, such as mutations and changes in gene expression, lead to abnormal chromosome content or aneuploidy that may facilitate cancer development. Furthermore, a defective checkpoint response is indicated in the development of drug resistance to microtubule poisons that are used in treatment of various blood and solid cancers for several decades. Mitotic slippage and senescence are important cell fates that occur even with an active mitotic checkpoint and are held responsible for the resistance. However, contradictory findings in both the scenarios of carcinogenesis and drug resistance have aroused questions on whether mitotic checkpoint defects are truly responsible for these dismal outcomes. Here, we discuss the possible contribution of the faulty checkpoint signaling in cancer development and drug resistance, followed by the latest research on this pathway for better outcomes in cancer treatment.
Insights
Mitotic checkpoint defects can lead to cancer and drug resistance, but recent findings question their direct role. Further research is exploring this pathway for improved cancer treatments.
Area of Science:
- Cell Biology
- Cancer Biology
- Genetics
Background:
- Malignant cells often exhibit dysregulated mitosis, leading to inaccurate chromosome segregation and aneuploidy.
- The mitotic checkpoint ensures faithful chromosome transmission, and its defects are linked to cancer development and drug resistance.
- Existing research presents contradictory findings regarding the direct role of mitotic checkpoint defects in carcinogenesis and drug resistance.
Purpose of the Study:
- To discuss the role of faulty checkpoint signaling in cancer development.
- To explore the contribution of mitotic checkpoint defects to drug resistance in cancer treatment.
- To review the latest research on the mitotic checkpoint pathway for improved cancer therapies.
Main Methods:
- Literature review and synthesis of existing research findings.
- Analysis of studies investigating mitotic checkpoint function in cancer.
- Examination of data on drug resistance mechanisms related to the mitotic checkpoint.
Main Results:
- Defects in the mitotic checkpoint can result in aneuploidy, a hallmark of cancer.
- Mitotic slippage and senescence, even with an active checkpoint, contribute to drug resistance.
- Contradictory evidence necessitates a re-evaluation of the direct causal link between checkpoint defects and adverse outcomes.
Conclusions:
- Faulty mitotic checkpoint signaling may contribute to cancer development and drug resistance, but its precise role is complex and debated.
- Further investigation into the nuances of mitotic checkpoint function is crucial for understanding cancer progression.
- Exploring novel therapeutic strategies targeting the mitotic checkpoint pathway holds promise for enhancing cancer treatment outcomes.
Related Concept Videos
Treatment Resistant Cancers
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Positive Regulator Molecules
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

